Improvement of the knock-in efficiency in the genome of human induced pluripotent stem cells using the CRISPR/Cas9 system

被引:0
|
作者
Gridina, M. M. [1 ]
机构
[1] SB RAS, Inst Cytol & Genet, Novosibirsk, Russia
来源
关键词
human induced pluripotent stem cells; CRISPR/Cas9; system; genome editing; knock-in efficiency;
D O I
10.18699/VJ18.446
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Human induced pluripotent stem (hiPS) cells are a powerful tool for biomedical research. The ability to create patient-specific pluripotent cells and their subsequent differentiation into any somatic cell type makes hiPS cells a valuable object for creating in vitro models of human diseases, screening drugs and a future source of cells for regenerative medicine. To realize entirely a potential of hiPScells, effective and precise methods for their genome editing are needed. The CRISPR/Cas9 system is the most widely used method for introducing site-specific double-stranded breaks into DNA. It allows genes of interest to be knocked out with high efficiency. However, knock-in into the target site of the genome is a much more difficult task. Moreover, many researchers have noted a low efficiency of introducing target constructs into the hiPS cells' genome. In this review, I attempt to describe the currently known information regarding the matter of increasing efficiency of targeted insertions into hiPS cells' genome. Here I will describe the most-effective strategies for designing the donor template for homology-directed repair, methods to manipulate the double-strand break repair pathways introduced by a nuclease, including control of CRISPR/Cas9 delivery time. A low survival rate of hiPS cells following genome editing experiments is another difficulty on the way towards successful knock-in, and here several highly effective approaches addressing it are proposed. Finally, I describe the most promising strategies, one-step reprogramming and genome editing, which allows gene-modified integration-free hiPS cells to be efficiently generated directly from somatic cells.
引用
收藏
页码:1026 / 1032
页数:7
相关论文
共 50 条
  • [31] Efficient knock-in at the chicken ovalbumin locus using adenovirus as a CRISPR/Cas9 delivery system
    Xiaolian Qin
    Ning Xiao
    Yu Xu
    Fengshuo Yang
    Xiaoli Wang
    Hao Hu
    Qingyou Liu
    Kuiqing Cui
    Xiaochuan Tang
    3 Biotech, 2019, 9
  • [32] Targeted knock-in of CreERT2 in zebrafish using CRISPR/Cas9
    Gokul Kesavan
    Juliane Hammer
    Stefan Hans
    Michael Brand
    Cell and Tissue Research, 2018, 372 : 41 - 50
  • [33] Generation of Tβ4 knock-in Cashmere goat using CRISPR/Cas9
    Li, Xiaocong
    Hao, Fei
    Hu, Xiao
    Wang, Hui
    Dai, Bai
    Wang, Xiao
    Liang, Hao
    Cang, Ming
    Liu, Dongjun
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (08): : 1743 - 1754
  • [34] Therapeutic genome editing using CRISPR/Cas9 for arrhythmogenic cardiomyopathy induced pluripotent stem cells derived cardiac tissues
    Caspi, O. Oren
    Chrona, S.
    Gepstein, A.
    Shiti, A.
    Huber, I.
    Arbel, G.
    Gepstein, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 3 - 3
  • [35] Modeling Transient Myeloproliferative Disorder Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology
    Barwe, Sonali
    Kolb, E. Anders
    Gopalakrishnapillai, Anilkumar
    BLOOD, 2019, 134
  • [36] Establishment of CRISPR/Cas9-Mediated Knock-in System for Porcine Cells with High Efficiency
    Juqing Zhang
    Zhenshuo Zhu
    Wei Yue
    Jiaxin Li
    Qiang Chen
    Yuan Yan
    Anmin Lei
    Jinlian Hua
    Applied Biochemistry and Biotechnology, 2019, 189 : 26 - 36
  • [37] Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology
    Barwe, Sonali P.
    Sidhu, Ishnoor
    Kolb, E. Anders
    Gopalakrishnapillai, Anilkumar
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 201 - 209
  • [38] Establishment of CRISPR/Cas9-Mediated Knock-in System for Porcine Cells with High Efficiency
    Zhang, Juqing
    Zhu, Zhenshuo
    Yue, Wei
    Li, Jiaxin
    Chen, Qiang
    Yan, Yuan
    Lei, Anmin
    Hua, Jinlian
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2019, 189 (01) : 26 - 36
  • [39] CRISPR/CAS9 MEDIATED GENOME ENGINEERING OF HUMAN MESENCHYMAL STEM CELLS
    van den Akker, G.
    van Beuningen, H.
    Davidson, E. Blaney
    van der Kraan, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A48 - A48
  • [40] Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology
    Mianne, Joffrey
    Bourguignon, Chloe
    Van, Chloe Nguyen
    Fieldes, Mathieu
    Nasri, Amel
    Assou, Said
    De Vos, John
    CELLS, 2020, 9 (05)